Verzenio(abemaciclibb)

[Indications of Verzenio(abemaciclibb)]

Verzenio(abemaciclibb) is suitable for the treatment of advanced or metastatic breast cancer.

[Verzenio(abemaciclibb) specification]

This product is a tablet, with four kinds of 5mg/10mg/15mg/25mg.

[How to take Verzenio(abemaciclibb)]

Depending on the combined medication, please consult your medication doctor.

[Notes for Verzenio(abemaciclibb)]

Breast cancer is the most common cancer among women in the world, which is higher than female lung cancer and liver cancer. It is estimated that there will be 200,000 new breast cancer patients in the United States in 2017. Breast cancer lurks in the human body and is not easy to be found. Generally, it is already in the middle and advanced stage, and some patients even have cancer metastasis to other organs and tissues of the body. This part of patients accounts for about 86% of the total breast cancer.

Verzenio is used for patients with negative HR and HER2 after endocrine therapy. The drug is approved for endocrine therapy alone or in combination with endocrine drugs, or for advanced and metastatic breast cancer that cannot be controlled by chemotherapy.